# Fresenius Kabi Austria Gmbh – FDA Inspection, Mar 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/fresenius-kabi-austria-gmbh/5de8cbe2-2f09-4d2d-9e06-6ffd76d8f8d1
Source feed: FDA_Inspections

> FDA inspection 1006761 of Fresenius Kabi Austria Gmbh, March 24, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006761
- Company Name: Fresenius Kabi Austria Gmbh
- Inspection Date: 2017-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1301512 - 2025-05-23
- FDA Inspection 1199272 - 2021-07-15
- FDA Inspection 1110698 - 2018-09-27
- FDA Inspection 906758 - 2014-11-07
- FDA Inspection 741633 - 2011-07-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/massoud-motamed/a8b363de-eb95-4bd3-8c05-9c34bbdbdc8a)

Company: https://www.keypedia.com/companies/fresenius-kabi-austria-gmbh/f0cc0bbb-a42b-4b48-9334-0426fb359254

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c